REFERENCES
1. S. Plotkin, W. Orenstein, P. Offit, Vaccines (Saunders, Philadelphia, 5th ed. 2008).
2. C. Scott, supplement to BioProcess Intl. 6 (6) s12–s18 (2008).
3. S. Fetzer, supplement to BioPharm Intl.
21 (1) s1–s6 (2008).
4. C.P. Steffy and L. Rosin, BioProcess Intl.
2 (4), s48–s57 (2004).
5. P. Holland-Moritz, BioPharm Bulletin (June 2006).
6. S. Srivastava, Vaccine World Summit March 1–3 (2011).
7. S.S. Ozturk, Cytotechnology
22, 3–16 (1996).
8. A. Heuer, The Bridge Editor's Note
36 (3) 3 (2006).
9. B. Kalbfuss et al., Jrnl. of Membrane Sci.
299, 251–260 (2007).
10. A. Karger, J. Schmidt, and T.C. Metten-leiter, Jrnl. Virol.
72, 7341–7348 (1998).
11. T. Vicente et al., Jrnl. of Membrane Sci.
311, 270–283 (2008).
12. T. Vicente et al., Gene Therapy
16, 766–775 (2009).
13. J. Tal, J Biomedical Sci. 7, 279–291 (2000).
14. WHO, Temperature Sensitivity of Vaccines, http://whqlibdoc.who.int/hq/2006/WHO_IVB_06.10_eng.pdf, accesses Sept. 6, 2011.
15. D. Chen and D. Kristensen, Expert Rev. Vaccines
8 (5), 547–557 (2009).
16. E. Boer, supplement to BioProcess Intl.
6 (10), 38–40 (2008).
17. N.W. Baylor, supplement to BioPharm Intl.
20 (8) (2007).
18. H. Pora, BioPharm Intl.
19 (6) (2006).
19. L. Leveen and S. Cox, presentation at IBC's 5th International Single-Use Applications for Biopharmaceutical Manufacturing
(San Diego, 2008).
20. D. Newman and S. Walker, presentation at IBC's 5th International Single-Use Applications for Biopharmaceutical Manufacturing
(San Diego, 2008).
21. G. Healy, Microbiologist
3, 28–30 (2006).
22. C. Scott, supplement to BioProcess Intl.
9, 3–42 (2010).
ACKNOWLEDGMENT
The author would like to acknowledge colleagues from Sartorius Stedim Biotech, Mahesh Prashad and Frank Meyeroltmanns for
sharing their knowledge and designing the generic schemes for platform processes in vaccine manufacturing. The author appreciates
the support of Dr. Uwe Gottschalk, vice-president of purification technologies at Sartorius Stedim Biotech. The author would
also like to acknowledge Anurag S. Rathore, PhD, a faculty member at the Indian Institute of Delhi, India, for his editorial
assistance with this paper. Rathore is a member of BioPharm International's Editorial Advisory Board and the author of the
journal's series on the Elements of Biopharmaceutical Production.
|
